Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Operating Leases (2023 - 2025)

Fractyl Health (GUTS) has disclosed Operating Leases for 3 consecutive years, with $26.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases fell 4.86% year-over-year to $26.3 million, compared with a TTM value of $26.3 million through Sep 2025, down 4.86%, and an annual FY2024 reading of $27.4 million, down 3.95% over the prior year.
  • Operating Leases was $26.3 million for Q3 2025 at Fractyl Health, down from $26.7 million in the prior quarter.
  • Across five years, Operating Leases topped out at $28.5 million in Q4 2023 and bottomed at $26.3 million in Q3 2025.
  • Average Operating Leases over 3 years is $27.5 million, with a median of $27.5 million recorded in 2024.
  • The sharpest move saw Operating Leases fell 3.95% in 2024, then fell 4.86% in 2025.
  • Year by year, Operating Leases stood at $28.5 million in 2023, then dropped by 3.95% to $27.4 million in 2024, then fell by 3.78% to $26.3 million in 2025.
  • Business Quant data shows Operating Leases for GUTS at $26.3 million in Q3 2025, $26.7 million in Q2 2025, and $27.0 million in Q1 2025.